Bone Health in Early Menopause Study
Part of Bones, joints & muscles, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how bone health changes in women with premature ovarian insufficiency (early menopause). It aims to understand the body's bone metabolism to help manage long-term health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 39 years old.
- You must have been diagnosed with premature ovarian insufficiency (early menopause).
- You cannot have a family history of early menopause or a condition present at birth affecting your ovaries.
- You cannot have had surgery or damage to your ovaries.
- You cannot have taken hormone therapy (including estrogen or herbal treatments) in the last 3 months.
- You must not have any serious medical conditions (like heart, liver, or kidney disease) or a mental health condition.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain blood markers relate to ovarian function in women with normal ovaries, diminished ovarian reserve (DOR), or primary ovarian insufficiency (POI). It may help doctors better understand these conditions.
This study follows women with premature ovarian insufficiency (POI) over time to understand how it affects their health. Researchers will collect samples and track health changes to learn more about the condition and its long-term effects.
This trial tests whether hormone replacement therapy (HRT) helps protect bone health in teenagers with premature ovarian insufficiency (POI). It compares HRT to a placebo and also includes healthy volunteers for comparison.
This trial tests whether injecting your own bone marrow cells can help reverse early menopause (premature ovarian insufficiency). It's for people who have not responded to standard hormone therapy.
This research study looks at genetic differences in women who have experienced early menopause or severe irregular periods before age 40, with no known cause. By comparing your genes to women with normal menstrual cycles, researchers hope to understand what causes this condition and potentially develop better treatments.
This study collects health information from women going through perimenopause (transition to menopause), menopause, early menopause, or premature ovarian insufficiency (POI—early loss of ovarian function). Researchers use this data to better understand these conditions and improve care.
Hear when a new Premature Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.